[go: up one dir, main page]

WO2006006269A8 - Blood-neutral-fat-lowering agent - Google Patents

Blood-neutral-fat-lowering agent

Info

Publication number
WO2006006269A8
WO2006006269A8 PCT/JP2005/004062 JP2005004062W WO2006006269A8 WO 2006006269 A8 WO2006006269 A8 WO 2006006269A8 JP 2005004062 W JP2005004062 W JP 2005004062W WO 2006006269 A8 WO2006006269 A8 WO 2006006269A8
Authority
WO
WIPO (PCT)
Prior art keywords
neutral
blood
fat
lowering agent
fat content
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2005/004062
Other languages
French (fr)
Japanese (ja)
Other versions
WO2006006269A1 (en
Inventor
Tsuyoshi Sakamoto
Toshihiko Tsuda
Junji Nagao
Yasuyuki Hasegawa
Yasufumi Itaya
Yuka Nakajima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kobayashi Pharmaceutical Co Ltd
Original Assignee
Kobayashi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kobayashi Pharmaceutical Co Ltd filed Critical Kobayashi Pharmaceutical Co Ltd
Publication of WO2006006269A1 publication Critical patent/WO2006006269A1/en
Publication of WO2006006269A8 publication Critical patent/WO2006006269A8/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

[PROBLEMS] To provide a blood-neutral-fat-lowering agent which is highly safe, can be taken or administered daily, and is effective in controlling the neutral-fat content in the blood. [MEANS FOR SOLVING PROBLEMS] Bitter melon treated with heating or an extract thereof functions to lower the neutral-fat content in the blood and is used as an active ingredient for a blood-neutral-fat-lowering agent.
PCT/JP2005/004062 2004-09-27 2005-03-09 Blood-neutral-fat-lowering agent Ceased WO2006006269A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004-280319 2004-09-27
JP2004280319 2004-09-27

Publications (2)

Publication Number Publication Date
WO2006006269A1 WO2006006269A1 (en) 2006-01-19
WO2006006269A8 true WO2006006269A8 (en) 2006-03-02

Family

ID=35783631

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2005/004062 Ceased WO2006006269A1 (en) 2004-09-27 2005-03-09 Blood-neutral-fat-lowering agent

Country Status (1)

Country Link
WO (1) WO2006006269A1 (en)

Also Published As

Publication number Publication date
WO2006006269A1 (en) 2006-01-19

Similar Documents

Publication Publication Date Title
WO2005097119A3 (en) Pten inhibitors
IL245489A0 (en) 1-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disorders
WO2006131952A8 (en) Novel analgesic treatment with prolonged effect
WO2008112565A3 (en) Method and composition for treating cancer
WO2006040688A3 (en) Inhibitors of acetylcholinesterase for treating skin diseases
AU2003249356A1 (en) Safe and effective nutritional supplement formulatins and associated regimens adapted to prevent and/or treat targeted diseases or medical or health conditions, and related methods
WO2006096439A3 (en) Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
WO2007143098A8 (en) Hepatocyte growth factor (hgf) binding proteins
WO2007143090A3 (en) Hepatocyte growth factor (hgf) binding proteins
WO2005123094A3 (en) Treatment or prevention of skin conditions or tissue conditions in animals using boryloxypyridylmethanones
WO2006053309A3 (en) Improved energy delivery devices and methods
WO2005034861A3 (en) A dried biotherapeutic composition, uses, and device and methods for administration thereof
EP1514539A3 (en) Micro-encapsulated topical analgesic for pain relief and sleeve comprising it
WO2006012213A3 (en) Composition and method for delivery of phytochemicals
WO2006020091A3 (en) Dietary supplements containing extracts of cinnamon and methods of using same to promote weight loss
WO2008014256A3 (en) Composition including superoxide dismutase and prickly-pear cactus for minimizing and preventing hangovers
WO2007074406A3 (en) Formulations for treatment of lipoprotein abnormalities comprising a statin a statin and a methylnicotinamide derivative
WO2007018588A8 (en) Stable pharmaceutical composition comprising linezolid form iv
WO2005094554A3 (en) Therapeutic agents, methods, and treatments
EP2436680A3 (en) Chroman derivatives, medicaments and use in therapy
WO2008006082A3 (en) Energy enhancing formulation
WO2007128924A3 (en) Aqueous tobacco leaf extract, uses thereof in the treatment of dependence
WO2005117913A3 (en) Ozonized pharmaceutical composition and method
WO2006138571A3 (en) Composition and methods for treating complications associated with ingestion of a medicinal, chemical or biological substance
WO2006006269A8 (en) Blood-neutral-fat-lowering agent

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

WR Later publication of a revised version of an international search report
NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase